| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.6M | — | — |
| R&D Expense | $149.2M | +9.4% | +18.3% |
| SG&A Expense | $45.0M | +43.0% | +47.3% |
| Operating Income | -$181.7M | -8.2% | -15.9% |
| Pre-tax Income | -$401.1M | -23.6% | -179.9% |
| Income Tax | $83K | -21.7% | -85.0% |
| Net Income | -$401.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $208.4M | -38.0% | +36.8% |
| Short-term Investments | $769.8M | +17.6% | +38.0% |
| Accounts Receivable | $10.4M | — | — |
| Current Assets | $1.02B | +0.4% | +38.1% |
| Total Assets | $1.37B | +8.4% | +41.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$356.7M | — | — |
| Capital Expenditures | $40.1M | — | — |
| Investing Cash Flow | -$66.9M | — | — |
| Financing Cash Flow | $432.6M | — | — |
| Free Cash Flow | -$396.8M | — | — |
| -178.9% |
| EPS (Basic) | -$0.48 | -17.1% | -128.6% |
| EPS (Diluted) | -$0.48 | -17.1% | -128.6% |
| $74.9M |
| +27.1% |
| +63.6% |
| Total Liabilities | $469.9M | +29.9% | +156.4% |
| Stockholders' Equity | $896.5M | -0.2% | +14.8% |